AUTHOR=Wu Peihong , Jiang Qingtao , Han Lei , Liu Xin 

TITLE=Systematic analysis and prediction for disease burden of ovarian cancer attributable to hyperglycemia: a comparative study between China and the world from 1990 to 2019

JOURNAL=Frontiers in Medicine

VOLUME=Volume 10 - 2023

YEAR=2023

URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1145487

DOI=10.3389/fmed.2023.1145487

ISSN=2296-858X

ABSTRACT=Background: Ovarian cancer is one of the most common female malignancies worldwide, and metabolic factors such as hyperglycemia are becoming potential risk factors. To analyze the disease burden and its change trend of ovarian cancer attributable to hyperglycemia in Chinese population from 1990 to 2019. 
Methods: Using the data released by Global Burden of Disease study 2019 (GBD 2019), we analyze the disease burden of ovarian cancer attributable to hyperglycemia in Chinese from 1990 to 2019 via morbidity, death, disability adjusted life years (DALY), compares it with the global population and predict the incidence and death trend in Chinese women for the next 10 years (2020-2029). 
Results: The incidence, death cases and DALY numbers of ovarian cancer attributable to hyperglycemia in Chinese in 2019 were 2,751, 1,758, and 44,615 person years, respectively, with an increase of 352.5%, 356.6% and 329.0% compared with 1990, and the growth rate was higher than the global level. The age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDR) in 2019 were 0.270/100,000, 0.164/100,000 and 4.103/100,000 respectively. Moreover, the average annual percent changes (AAPC) were 2.3%, 2.0% and 2.0% respectively, all higher than the global average. The disease burden of ovarian cancer attributable to hyperglycemia increased with age, reaching a peak in the 45-75 age group. The prediction of neural network model showed that the incidence and death of the disease would remain high and rising in the next 10 years. 
Conclusion: The disease burden caused by ovarian cancer attributable to hyperglycemia in Chinese accounts for a large proportion globally, and the ASIR, ASMR and ASDR are increasing year by year. We should continue to pay attention to the role of metabolic factors such as hyperglycemia in the occurrence and development of ovarian cancer, do a good job in tertiary prevention, and strive to reduce health losses.